Frontiers in Pharmacology
Cholesterol drug class linked to lower dementia risk
Among 31,604 matched pairs, people taking the drugs had a dementia hazard ratio of 0.454 compared with statin users, indicating lower relative risk.Among 31,604 matched pairs, people taking the drugs had a dementia hazard ratio of 0.454 compared with statin users, indicating lower relative risk.

Cohort studyAll-cause dementia
Who was studiedOlder adults with hyperlipidemia, median 782 days, against statin users
What changedDementia risk was 55% lower among PCSK9 inhibitor users than statin users
The catchInsurance access, adherence, and preventive care could confound the apparent dementia benefit



